Your browser doesn't support javascript.
loading
European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making.
Andratschke, Nicolaus; Willmann, Jonas; Appelt, Ane L; Alyamani, Najlaa; Balermpas, Panagiotis; Baumert, Brigitta G; Hurkmans, Coen; Høyer, Morten; Langendijk, Johannes A; Kaidar-Person, Orit; van der Linden, Yvette; Meattini, Icro; Niyazi, Maximilian; Reynaert, Nick; De Ruysscher, Dirk; Tanadini-Lang, Stephanie; Hoskin, Peter; Poortmans, Philip; Nieder, Carsten.
Afiliação
  • Andratschke N; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Electronic address: nicolaus.andratschke@usz.ch.
  • Willmann J; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Appelt AL; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
  • Alyamani N; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Balermpas P; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Baumert BG; Institute of Radiation-Oncology, Cantonal Hospital of Graubünden, Chur, Switzerland.
  • Hurkmans C; Department of Radiation Oncology, Catharina Hospital Eindhoven, Eindhoven, Netherlands.
  • Høyer M; Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.
  • Langendijk JA; Department of Radiation Oncology, University Medical Center Groningen, Groningen, Netherlands.
  • Kaidar-Person O; Breast Cancer Radiation Therapy Unit, Sheba Medical Center, Ramat Gan, Israel; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel; Department of Radiation Oncology (Maastro), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, Netherla
  • van der Linden Y; Department of Radiotherapy, University Medical Centre, Leiden, Netherlands; Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands.
  • Meattini I; Radiation Oncology Unit, Oncology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy; Department of Experimental and Clinical Biomedical Sciences M Serio, University of Florence, Florence, Italy.
  • Niyazi M; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany; Bavarian Cancer Research Center (BZKF), Munich, Germany.
  • Reynaert N; Department of Medical Physics, Institut Jules Bordet, Brussels, Belgium; Laboratory of Medical Radiophysics, Université Libre de Bruxelles, Brussels, Belgium.
  • De Ruysscher D; Department of Radiation Oncology (Maastro), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, Netherlands.
  • Tanadini-Lang S; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Hoskin P; Mount Vernon Cancer Centre and Division of Cancer Sciences, University of Manchester, Manchester, UK.
  • Poortmans P; Department of Radiation Oncology, Iridium Netwerk, Wilrijk-Antwerp, Belgium; Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk-Antwerp, Belgium.
  • Nieder C; Department of Oncology and Palliative Medicine, Nordland Hospital Trust, Bodø, Norway; Department of Clinical Medicine, Faculty of Health Sciences, UiT the Arctic University of Norway, Tromsø, Norway.
Lancet Oncol ; 23(10): e469-e478, 2022 10.
Article em En | MEDLINE | ID: mdl-36174633

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Reirradiação / Neoplasias Tipo de estudo: Guideline / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Reirradiação / Neoplasias Tipo de estudo: Guideline / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article